|
Severe Asthma: Clinical Conundrum
Pharmacy Times Severe asthma—a heterogeneous disease that requires treatment with high-dose inhaled corticosteroids—affects 5% to 10% of asthma patients. The condition is costly to treat, consuming more than its share of health care resources. A comprehensive … |
View full post on asthma – Google News